Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

VEENA R WATWE

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1417120221
CMS profile
18441
Location
HOUSTON, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$7,960.01

165 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

Page 2 of 4; records 51–100 of 165 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

VEENA R WATWE

NPI 1417120221 · CMS profile ID 18441

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

HOUSTON, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 165 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1417120221?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
VEENA R WATWE, NPI 1417120221, CMS profile ID 18441. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 165 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1417120221?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). VEENA R WATWE, NPI 1417120221, CMS profile ID 18441. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 165 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1417120221?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
VEENA R WATWE, NPI 1417120221, CMS profile ID 18441, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 165 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1417120221?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

165 matching records · $7,960.01 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 165 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 165.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Amgen Inc. $13.8909/23/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826541305 CMS
Horizon Therapeutics plc $27.5609/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797226571 CMS
Zealand Pharma US, Inc. $22.0209/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 800231279 CMS
Amarin Pharma Inc. $19.0309/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815351365 CMS
VIVUS LLC $18.4509/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 814343149 CMS
SANOFI-AVENTIS U.S. LLC $17.8809/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843612637 CMS
Abbott Laboratories $6.0109/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833879249 CMS
Lilly USA, LLC $15.1009/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818778451 CMS
MannKind Corporation $13.5609/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821084647 CMS
PFIZER INC. $11.2709/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832834855 CMS
AstraZeneca Pharmaceuticals LP $20.6108/31/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834354701 CMS
Merck Sharp & Dohme Corporation $18.9708/31/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848605657 CMS
Esperion Therapeutics, Inc. $17.0408/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838434021 CMS
Zealand Pharma US, Inc. $24.7608/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 800231277 CMS
MannKind Corporation $14.5408/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821084639 CMS
MannKind Corporation $8.8608/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821084643 CMS
Amgen Inc. $13.8408/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825853335 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.9108/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763566122 CMS
Abbott Laboratories $3.5608/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833879237 CMS
Abbott Laboratories $8.4308/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833879243 CMS
Alexion Pharmaceuticals, Inc. $18.5508/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783121879 CMS
Novo Nordisk Inc $20.9408/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810902241 CMS
MannKind Corporation $6.3908/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821084635 CMS
MannKind Corporation $9.9107/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821084631 CMS
Novo Nordisk Inc $22.6307/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811561981 CMS
Radius Health, Inc. $15.3507/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830748261 CMS
Teva Pharmaceuticals USA, Inc. $14.7807/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 839637081 CMS
Lilly USA, LLC $13.9707/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818780457 CMS
SANOFI-AVENTIS U.S. LLC $17.5407/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843612621 CMS
Zealand Pharma US, Inc. $100.6907/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 800231275 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.3507/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763566124 CMS
MannKind Corporation $13.1307/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821084627 CMS
AbbVie Inc. $11.7307/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 796231723 CMS
Novo Nordisk Inc $19.7807/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810901691 CMS
AstraZeneca Pharmaceuticals LP $16.8307/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834341287 CMS
Merck Sharp & Dohme Corporation $18.5807/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848340441 CMS
SANOFI-AVENTIS U.S. LLC $16.1107/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843612601 CMS
Abbott Laboratories $4.8407/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833879257 CMS
VIVUS LLC $14.0707/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 814343147 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.7607/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763566126 CMS
MannKind Corporation $20.1806/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821084623 CMS
Xeris Pharmaceuticals, Inc. $22.4006/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837450785 CMS
AstraZeneca Pharmaceuticals LP $18.3506/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834346725 CMS
Amgen Inc. $18.3006/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825853347 CMS
SANOFI-AVENTIS U.S. LLC $13.1006/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843612597 CMS
AbbVie Inc. $16.3306/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 796231721 CMS
MannKind Corporation $5.3606/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821084619 CMS
Abbott Laboratories $3.9806/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815533629 CMS
DEXCOM, INC. $15.2506/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845303583 CMS
Amneal Pharmaceuticals LLC $16.0206/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829684285 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $32,273.00 292
PY2020 $11,961.49 183
PY2021 $7,960.01 165
PY2022 $5,247.94 177
PY2023 $37,439.05 256
PY2024 $33,130.51 205
PY2025 $28,734.20 178

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $298,936.54 15
PY2024 Recipient $16,028.73 4
PY2024 Principal investigator $118,016.41 8
PY2023 Recipient $254.64 1
PY2023 Principal investigator $94,029.12 3
PY2022 Principal investigator $308,272.09 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

15 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $5,587.00 12/31/2025 Non-covered Recipient Entity
ENDOCRINE AND PSYCHIATRY CENTER
A Phase 2/3 multicenter, double blinded, randomized, dose-conversion, active control study examining the efficacy and safety of Armour Thyroid compared to synthetic T4 for the treatment of adults with primary hypothyroidism No dispute reported 06/30/2026 1202535017
Principal investigator 1 Novartis Pharmaceuticals Corporation $13,703.87 12/17/2025 Non-covered Recipient Entity
NORTHWEST HOUSTON NEUROLOGY AND COMPREHENSIVE SLEEP MEDICINE CENTER
A Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in High-risk Primary Prevention Patients (VICTORION-1 PREVENT) No dispute reported 06/30/2026 1190308632
Principal investigator 1 ABBVIE INC. $8,383.50 12/05/2025 Non-covered Recipient Entity
ENDOCRINE AND PSYCHIATRY CENTER
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202529220
Principal investigator 1 ABBVIE INC. $19,449.45 11/05/2025 Non-covered Recipient Entity
ENDOCRINE AND PSYCHIATRY CENTER
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202522351
Principal investigator 1 ABBVIE INC. $17,000.55 10/09/2025 Non-covered Recipient Entity
ENDOCRINE AND PSYCHIATRY CENTER
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202514829
Principal investigator 1 ABBVIE INC. $24,595.65 09/04/2025 Non-covered Recipient Entity
ENDOCRINE AND PSYCHIATRY CENTER
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202509816
Principal investigator 1 ABBVIE INC. $27,545.40 08/06/2025 Non-covered Recipient Entity
ENDOCRINE AND PSYCHIATRY CENTER
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202502356
Principal investigator 1 ABBVIE INC. $16,100.10 07/02/2025 Non-covered Recipient Entity
ENDOCRINE AND PSYCHIATRY CENTER
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202494703
Principal investigator 1 ABBVIE INC. $39,345.75 06/03/2025 Non-covered Recipient Entity
ENDOCRINE AND PSYCHIATRY CENTER
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202489271
Principal investigator 1 ABBVIE INC. $28,468.80 05/07/2025 Non-covered Recipient Entity
ENDOCRINE AND PSYCHIATRY CENTER
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202483929
Principal investigator 1 ABBVIE INC. $17,053.20 04/03/2025 Non-covered Recipient Entity
ENDOCRINE AND PSYCHIATRY CENTER
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202468711
Principal investigator 1 ABBVIE INC. $10,311.30 03/07/2025 Non-covered Recipient Entity
ENDOCRINE AND PSYCHIATRY CENTER
M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202459341
Principal investigator 1 ABBVIE INC. $27,309.15 02/06/2025 Non-covered Recipient Entity
ENDOCRINE AND PSYCHIATRY CENTER
M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202448258
Principal investigator 1 Shionogi Inc $5,215.26 01/15/2025 Non-covered Recipient Entity
CLINICAL RESEARCH SOLUTION LLC
A Phase 2, Multicenter, Randomized, Double-blind, Dose-ranging, Placebo-controlled Study to Assess the Safety and Efficacy of S-309309 in Obese Adults No dispute reported 06/30/2026 1250719822
Principal investigator 1 Novartis Pharmaceuticals Corporation $38,867.56 01/02/2025 Non-covered Recipient Entity
NORTHWEST HOUSTON NEUROLOGY AND COMPREHENSIVE SLEEP MEDICINE CENTER
A Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in High-risk Primary Prevention Patients (VICTORION-1 PREVENT) No dispute reported 06/30/2026 1190308634